Clinical Trial

Lymphocyte Subpopulations in Peripheral Giant Cell Granuloma

Completed
View on ClinicalTrials.gov →
Summary
Peripheral giant cell granuloma (PGCG) is a non-neoplastic inflammatory lesion of gingival tissues. This study aims to evaluate and compare lymphocyte subpopulations in PGCG tissues and adjacent healthy gingival tissues obtained from the same individuals. A total of 28 systemically healthy, non-smoking patients diagnosed with PGCG are included in this study. Biopsy samples are collected during surgical excision of PGCG lesions, and corresponding healthy gingival tissues are obtained from the same patients. Immunohistochemical analysis is performed to assess lymphocyte subpopulations, including CD3, CD4, CD8, CD20, and CD79a. The proportions of these cells are compared between diseased and healthy tissues.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-04-18.
Trial Details
NCT Number NCT07551310
Lead Sponsor Ataturk University
Conditions Peripheral Giant Cell Granuloma, Gingival Lesions, Gingival Enlargement
Enrollment 28 participants
Start Date 2026-01-01
Primary Completion 2026-03-01 (estimated)
Study Completion 2026-03-30 (estimated)
Updated on ClinicalTrials.gov 2026-05-18